ASCEND CLINICAL RESEARCH
DEAD

Serial Number

87331203

Owner

ASCEND INNOVATIONS, INC

Attorney

Roger H. Bora

Filing Date

Feb 10, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ASCEND CLINICAL RESEARCH Trademark

Serial Number: 87331203

ASCEND CLINICAL RESEARCH is a trademark filed by ASCEND INNOVATIONS, INC on February 10, 2017. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

ASCEND INNOVATIONS, INC (9 trademarks)

DAYTON, OH 45402

Entity Type: 03

Trademark Details

Filing Date

February 10, 2017

Registration Date

Not Registered

Goods & Services

Conduct training in the field of clinical research to Principal Investigators, Clinical Subjects, Sponsors and other persons; education services, namely, providing classes, seminars, and workshops to Principal Investigators, Clinical Subjects, Sponsors and other persons in the field of clinical research

Providing site management activities in the field of clinical research in the nature of collecting, reposing, analyzing data to support scientific advancements and unmet clinical needs and prepare documentation for presentations to Institutional Review Boards, Subjects for consenting into trials and the Food and Drug Administration and managing data analytics for clinical research and studies conducted through an associated network of regional hospitals and healthcare organizations, including statistical analysis and reporting services for business purposes

Conducting medical device and pharmaceutical clinical studies and trials for others, namely, conducting early phase clinical research, observational studies and Phase I and II clinical trials for medical devices and pharmaceuticals; conducting clinical trials for others; providing clinical research information in the field of clinical trials, including data and information to support scientific advancements and unmet clinical needs for use with preparing documentation for presentations to Institutional Review Boards, Subjects for consenting into trials and the Food and Drug Administration

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 27, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 27, 2021 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 5, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jan 5, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jan 5, 2021 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 10, 2020 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 8, 2020 RCSC
ASSIGNED TO LIE
Apr 30, 2020 ALIE
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 30, 2019 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 4, 2019 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 25, 2018 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 27, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 27, 2018 GNSL
SUSPENSION LETTER WRITTEN
Feb 27, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2018 CRFA
ASSIGNED TO LIE
Feb 5, 2018 ALIE
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 26, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 26, 2018 REAP
NOTICE OF REVIVAL - E-MAILED
Jan 26, 2018 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 26, 2018 TROA
PETITION TO REVIVE-GRANTED
Jan 26, 2018 PETG
TEAS PETITION TO REVIVE RECEIVED
Jan 26, 2018 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 5, 2017 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 5, 2017 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 9, 2017 GNRN
NON-FINAL ACTION E-MAILED
May 9, 2017 GNRT
NON-FINAL ACTION WRITTEN
May 9, 2017 CNRT
ASSIGNED TO EXAMINER
May 8, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 15, 2017 NWOS
NEW APPLICATION ENTERED
Feb 14, 2017 NWAP